Hello

Your subscription is almost coming to an end. Don’t miss out on the great content on Nation.Africa

Ready to continue your informative journey with us?

Hello

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features.

Reclaim your full access. Click below to renew.

Subscribe for a month to get full access

Premium

European Commission approves first twice-yearly HIV medication

HIV twice yearly injection

European Commission has approved twice-yearly injections and tablets for treating HIV infection.

Photo credit: Shutterstock

By  Amina Wako

What you need to know:

  • The new treatment would enable more people showing resistance to current regimens to get on treatment.
  • The European Commission approval applies to all 27 member states, Norway, Iceland and Liechtenstein.

European Commission has approved twice-yearly injections and tablets for treating HIV infection in adults with multi-drug resistant HIV.

The twice-yearly antiretroviral is for treating people with multidrug-resistant HIV who cannot otherwise construct a fully suppressive regimen.

Related

In the headlines